Travere Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €1.02B +27.9% €435.90M +55.8% 42.5% +0.076 pp N/A N/A
    (estimated) €801.06M +25.0% €279.82M +95.2% 34.9% +0.13 pp N/A N/A
    (estimated) €640.82M +28.0% €143.33M +402.1% 22.4% +0.17 pp €49.97M -1,071.5% 7.8% +0.088 pp
    (estimated) €500.68M +40.2% €28.55M -138.0% 5.7% +0.27 pp -€5.14M -104.5% -1.0% -0.33 pp
    (estimated) €357.22M +79.6% -€75.03M -72.6% -21.0% +1.2 pp €113.14M -197.3% 31.7% +0.90 pp
    €198.89M +60.5% -€274.26M +188.6% -137.9% -0.61 pp -€116.23M -51.2% -58.4% +1.3 pp
    €123.88M -31.5% -€95.02M -60.0% -76.7% +0.55 pp -€238.27M +77.1% -192.3% -1.2 pp
    €180.84M -6.8% -€237.53M +54.6% -131.3% -0.52 pp -€134.54M -1,785.4% -74.4% -0.79 pp
    €194.04M +14.7% -€153.61M +6.3% -79.2% +0.063 pp €7.98M -87.9% 4.1% -0.35 pp
    €169.16M +13.1% -€144.52M +15.7% -85.4% -0.019 pp €65.76M -280.8% 38.9% +0.63 pp
    €149.55M +6.8% -€124.90M +42.6% -83.5% -0.21 pp -€36.38M +711.3% -24.3% -0.21 pp
    €140.09M +6.0% -€87.58M +71.9% -62.5% -0.24 pp -€4.48M -124.6% -3.2% -0.17 pp
    €132.15M +16.0% -€50.95M +24.7% -38.6% -0.027 pp €18.26M +107.3% 13.8% +0.061 pp
    €113.95M +33.7% -€40.86M -140.9% -35.9% -1.5 pp €8.81M +59.5% 7.7% +0.012 pp
    €85.20M +254.2% €100.00M -205.7% 117.4% +5.1 pp €5.52M -115.5% 6.5% +1.5 pp
    €24.06M +∞% -€94.62M +228.0% -393.4% -3.9 pp -€35.73M +247.9% -148.5% -1.5 pp
    €0.00 +NaN% -€28.85M +228,051.8% N/A -€10.27M +24,571,026.5% N/A
    €0.00 +NaN% -€12.65K -∞% N/A -€41.79 -92.9% N/A
    €0.00 +NaN% €0.00 +NaN% N/A -€587.68 -95.5% N/A
    €0.00 +NaN% €0.00 -100.0% N/A -€13.20K -15.3% N/A
    €0.00 -€15.58K N/A -€15.58K N/A

    Notifications